Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program-Reference-Cited by-同舟云学术

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

Published:2018-08 Issue:4 Volume:16 Page:e945-e951
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Procopio Giuseppe,Prisciandaro Michele,Iacovelli Roberto,Cortesi Enrico^ORCID,Fornarini Giuseppe,Facchini Gaetano^ORCID,Cartenì Giacomo,Sabbatini Roberto,Del Bene Gabriella^ORCID,Galli Luca,Caserta Claudia,Multari Andrea Giovanni,Bregni Marco,Massari Francesco,Buti Sebastiano^ORCID,De Giorgi Ugo,Zustovich Fable,Milella Michele,Calabrò Fabio,Mancini Maria Laura,Tortora Giampaolo,Vernieri Claudio,Santini Daniele,Sorarù Mariella,Ricotta Riccardo^ORCID,Masini Cristina,Tucci Marcello,Fedeli Stefano Luzi,Ortega Cinzia,Mecozzi Antonella,Ratta Raffaele,Sternberg Cora N.,Verzoni Elena

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference18 articles.

1. Renal cancer;Capitanio;Lancet,2016

2. Targeting the hepatocyte growth factor/c-Met signaling pathway in renal cell carcinoma;Harschman;Cancer J,2013

3. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET;Rankin;Proc Natl Acad Sci U S A,2014

4. Kinase requirements in human cells: III. Altered kinase requirements in VHL−/− cancer cells detected in a pilot synthetic lethal screen;Bommi-Reddy;Proc Natl Acad Sci U S A,2008

5. c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma;Gibney;Ann Oncol,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients—Real-World Experience in a Single-Center Retrospective Study and Narrative Review;Medicina;2024-02-26

2. Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England;Drugs - Real World Outcomes;2024-01-24

3. Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence;Clinical Genitourinary Cancer;2023-11

4. Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma;Japanese Journal of Clinical Oncology;2023-07-29

5. Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges;Frontiers in Oncology;2023-03-07